Coronary stent thrombosis: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
'''Associate Editors-In-Chief:''' | '''Associate Editors-In-Chief:''' [[William J. Gibson]], Harvard Medical School; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S. | ||
{{Editor | {{Editor Join}} | ||
==[[Stent thrombosis introduction| Introduction]]== | ==[[Stent thrombosis introduction| Introduction]]== | ||
Line 25: | Line 24: | ||
==[[Stent thrombosis prevention|Prevention]]== | ==[[Stent thrombosis prevention|Prevention]]== | ||
{{SIB}} | {{SIB}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Revision as of 13:06, 18 May 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editors-In-Chief: William J. Gibson, Harvard Medical School; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Introduction
Definition
Etiology
Incidence
Relation to Bare Metal Stents | Relation to Drug Eluting Stents | Relation to antiplatelet medications